News Medical3d
Inflammation and metabolic syndrome contribute to prostate enlargement in aging men
A new research paper was published by Aging (Aging-US) on January 6, 2025, in Volume 17, Issue 1, titled "The profile of ...
Benign Prostatic Hyperplasia Surgical Treatment Market to Hit USD 17.19 Billion by 2030 with 5.3% CAGR | MarketsandMarkets™
The global Benign Prostatic Hyperplasia Surgical Treatment market, valued at US$11.92 billion in 2023, is forecasted to grow ...
Your Good Health: Tenderness develops in man’s breast after taking finasteride
Finasteride is used to treat benign prostatic hyperplasia. For a very few men, this causes pain in the breast tissue.
Holmium Laser of the Prostate Double-n Technology promising for benign prostatic hyperplasia
For men with benign prostatic hyperplasia (BPH), transurethral Holmium Laser of the Prostate (HoLEP) with Double-n Technology shows promise for improving urinary symptoms while better preserving ...
PM News on MSN13d
Doctor reacts to belief on sex and prostate cancer risk
By Temitope PonleDr Sam Adegboye, a Physician, has debunked the claim that frequent sexual activity reduces the risk of prostate cancer in men.Adegboye is the Assistant Chief Medical Officer and ...
Armed robbery in Revesby3d
Inflammation, Metabolic Syndrome Tied to BPH
Our research results suggest that pro-inflammatory mediators and suppressors of inflammation are involved in the development ...
Hosted on MSN16d
HoLEP Double-n Technology Promising for Benign Prostatic Hyperplasia
THURSDAY, Feb. 6, 2025 (HealthDay News) -- For men with benign prostatic hyperplasia (BPH), transurethral Holmium Laser of the Prostate (HoLEP) with Double-n Technology shows promise for improving ...
Medscape9d
Alfuzosin Hydrochloride for the Treatment of Benign Prostatic Hyperplasia
Alpha-1 adrenergic antagonists produce greater improvement in voiding symptoms and urinary flow rates than finasteride alone. No additive or synergistic effects have been proven when terazosin was ...